Table 3 Long-term outcomes of EGBS in patient without cholecystectomy
Outcomes | n = 24 |
|---|---|
Median follow-up periods, days (range) | 236 (48–1018) |
Late adverse event | 8 (33%) |
Recurrent cholecystitis | 4 (17%) |
Cholangitis | 0 (0%) |
Duodenal penetration by the stent | 2 (8%) |
Migration | 2 (8%) |
Cause of stent dysfunction | |
Obstruction | 3 |
Migration | 1 |
TRBO, days (range) | 527 (322–NA) |